Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype

Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype

Abstract Background Plasma‐derived tumour‐specific cell‐free nucleic acids are increasingly utilized as a minimally invasive, real‐time biomarker approach in many solid tumours. Circulating tumour DNA of melanoma‐specific mutations is currently the best studied liquid biopsy biomarker for melanoma....

תיאור מלא

מידע ביבליוגרפי
Main Authors: Lea Jessica Albrecht, Anna Höwner, Klaus Griewank, Smiths S. Lueong, Nils vonNeuhoff, Peter A. Horn, Antje Sucker, Annette Paschen, Elisabeth Livingstone, Selma Ugurel, Lisa Zimmer, Susanne Horn, Jens T. Siveke, Dirk Schadendorf, Renáta Váraljai, Alexander Roesch
פורמט: Article
שפה:English
יצא לאור: Wiley 2022-11-01
סדרה:Clinical and Translational Medicine
נושאים:
biomarker
cell‐free RNA
cfRNA
liquid biopsy
melanoma
גישה מקוונת:https://doi.org/10.1002/ctm2.1090

אינטרנט

https://doi.org/10.1002/ctm2.1090

פריטים דומים